Loading organizations...
Karst Peak Capital is a public equities-focused investment management firm based in Central, Hong Kong, with a team in Sydney, specializing in concentrated portfolios of high-conviction small- and mid-cap businesses. The firm employs a private equity approach to public markets, identifying promising companies before broader market recognition, with a particular emphasis on global businesses from Australia and New Zealand across consumer, healthcare, and technology sectors. Backed by Tiger Management, Karst Peak Capital operates with fewer than 25 employees and has generated a strong track record in Australasia. Hashan De Silva, the firm's Head of Healthcare Research, notably launched the separate venture capital fund KP-RX, which focuses on Australian and New Zealand healthcare companies and was seeded by founder Adam Leitzes. Karst Peak Capital was founded in 2012 by Adam Leitzes.
Karst Peak Capital has 2 tracked investments across 2 companies. The latest tracked deal is $80.0M Other Equity in Tessa Therapeutics in December 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 20, 2017 | Tessa Therapeutics | $80.0M Other Equity | Temasek | EDBI, Heliconia Capital, Heritas Capital |
| Aug 1, 2017 | Treebo Hotels | $34.0M Series C | Karst Peak Capital, Ward Ferry | Matrix Partners India, Speciale Invest, Narayan Ramachandran, Matrix, Saif Partners |
